188 related articles for article (PubMed ID: 19279048)
1. Reduced susceptibility of multidrug-resistant Acinetobacter baumannii to tigecycline in combination with 1-(1-naphthylmethyl)-piperazine is not a pH-dependent phenomenon.
Wareham DW; Gordon NC; Casals JB; Bean DC
J Antimicrob Chemother; 2009 May; 63(5):1075-6. PubMed ID: 19279048
[No Abstract] [Full Text] [Related]
2. In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii.
Capone A; D'Arezzo S; Visca P; Petrosillo N;
J Antimicrob Chemother; 2008 Aug; 62(2):422-3. PubMed ID: 18424790
[No Abstract] [Full Text] [Related]
3. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii.
Navon-Venezia S; Leavitt A; Carmeli Y
J Antimicrob Chemother; 2007 Apr; 59(4):772-4. PubMed ID: 17353223
[TBL] [Abstract][Full Text] [Related]
4. Comparative in vitro activities of tigecycline and 11 other antimicrobial agents against 215 epidemiologically defined multidrug-resistant Acinetobacter baumannii isolates.
Seifert H; Stefanik D; Wisplinghoff H
J Antimicrob Chemother; 2006 Nov; 58(5):1099-100. PubMed ID: 16980293
[No Abstract] [Full Text] [Related]
5. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan.
Liu JW; Wang LS; Cheng YJ; Hsu GJ; Lu PL; Liu YC; Chen CM; Lee CM; Sun W; Jang TN; Chiang PC; Chuang YC; Lin HC; Shi ZY; Kung HC; Huang CH; Tsao SM; Lu CT; Liao CH; Hsueh PR
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S188-91. PubMed ID: 19013353
[TBL] [Abstract][Full Text] [Related]
6. Colistin and tigecycline susceptibility among multidrug-resistant Acinetobacter baumannii isolated from ventilator-associated pneumonia.
Dizbay M; Altuncekic A; Sezer BE; Ozdemir K; Arman D
Int J Antimicrob Agents; 2008 Jul; 32(1):29-32. PubMed ID: 18539006
[TBL] [Abstract][Full Text] [Related]
7. Postantibiotic effects of tigecycline, colistin sulfate, and levofloxacin alone or tigecycline-colistin sulfate and tigecycline-levofloxacin combinations against Acinetobacter baumannii.
Ozbek B; Sentürk A
Chemotherapy; 2010; 56(6):466-71. PubMed ID: 21088399
[TBL] [Abstract][Full Text] [Related]
8. Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii.
Schafer JJ; Goff DA; Stevenson KB; Mangino JE
Pharmacotherapy; 2007 Jul; 27(7):980-7. PubMed ID: 17594203
[TBL] [Abstract][Full Text] [Related]
9. Mutant prevention concentration of tigecycline for carbapenem-susceptible and -resistant Acinetobacter baumannii.
Cui JC; Liu YN; Chen LA
J Antibiot (Tokyo); 2010 Jan; 63(1):29-31. PubMed ID: 19911030
[No Abstract] [Full Text] [Related]
10. Antimicrobial susceptibility of extended-spectrum beta-lactamase producers and multidrug-resistant Acinetobacter baumannii throughout the United States and comparative in vitro activity of tigecycline, a new glycylcycline antimicrobial.
Hoban DJ; Bouchillon SK; Dowzicky MJ
Diagn Microbiol Infect Dis; 2007 Apr; 57(4):423-8. PubMed ID: 17403448
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the Etest and broth microdilution method for tigecycline susceptibility testing against clinical isolates of Acinetobacter baumannii from Taiwan.
Liu JW; Jang TN; Cheng YJ; Hsu GJ; Sun W; Lu CT; Hsueh PR;
Int J Antimicrob Agents; 2010 Feb; 35(2):201-2. PubMed ID: 19892530
[No Abstract] [Full Text] [Related]
12. In vitro synergistic activity of tigecycline and colistin against XDR-Acinetobacter baumannii.
Dizbay M; Tozlu DK; Cirak MY; Isik Y; Ozdemir K; Arman D
J Antibiot (Tokyo); 2010 Feb; 63(2):51-3. PubMed ID: 19942947
[TBL] [Abstract][Full Text] [Related]
13. Multidrug efflux inhibition in Acinetobacter baumannii: comparison between 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-beta-naphthylamide.
Pannek S; Higgins PG; Steinke P; Jonas D; Akova M; Bohnert JA; Seifert H; Kern WV
J Antimicrob Chemother; 2006 May; 57(5):970-4. PubMed ID: 16531429
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii and Stenotrophomonas maltophilia.
Insa R; Cercenado E; Goyanes MJ; Morente A; Bouza E
J Antimicrob Chemother; 2007 Mar; 59(3):583-5. PubMed ID: 17213264
[No Abstract] [Full Text] [Related]
15. Rapid development of Acinetobacter baumannii resistance to tigecycline.
Reid GE; Grim SA; Aldeza CA; Janda WM; Clark NM
Pharmacotherapy; 2007 Aug; 27(8):1198-201. PubMed ID: 17655518
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of tigecycline against clinical isolates of multidrug-resistant Acinetobacter baumannii in Siriraj Hospital, Thailand.
Tiengrim S; Tribuddharat C; Thamlikitkul V
J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S102-5. PubMed ID: 17718251
[TBL] [Abstract][Full Text] [Related]
17. Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report.
Peleg AY; Potoski BA; Rea R; Adams J; Sethi J; Capitano B; Husain S; Kwak EJ; Bhat SV; Paterson DL
J Antimicrob Chemother; 2007 Jan; 59(1):128-31. PubMed ID: 17082201
[TBL] [Abstract][Full Text] [Related]
18. In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii.
Song JY; Kee SY; Hwang IS; Seo YB; Jeong HW; Kim WJ; Cheong HJ
J Antimicrob Chemother; 2007 Aug; 60(2):317-22. PubMed ID: 17540672
[TBL] [Abstract][Full Text] [Related]
19. Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
Jamal W; Salama M; Dehrab N; Al Hashem G; Shahin M; Rotimi VO
J Hosp Infect; 2009 Jul; 72(3):234-42. PubMed ID: 19493588
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibility among Acinetobacter calcoaceticus-baumannii complex and Enterobacteriaceae collected as part of the Tigecycline Evaluation and Surveillance Trial.
Halstead DC; Abid J; Dowzicky MJ
J Infect; 2007 Jul; 55(1):49-57. PubMed ID: 17250897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]